Thomas Kellerth
Impact in
-
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Heart Failure Treatment and Management
- Surgery top 1%
- Coronary Interventions and Diagnostics
- Cardiac and Coronary Surgery Techniques
- Lipoproteins and Cardiovascular Health
Papers in
-
- Acute Myocardial Infarction Research 23
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Cardiovascular Issues in Pregnancy 1
- Cardiac Valve Diseases and Treatments 1
- Surgery 16
- Coronary Interventions and Diagnostics 16
- Co-authors
- Tomas Jernberg (13 shared papers)Joakim Alfredsson (11 shared papers)David Erlinge (11 shared papers)Troels Yndigegn (9 shared papers)Bertil Lindahl (10 shared papers)Annica Ravn‐Fischer (8 shared papers)Claes Held (7 shared papers)Stefan Karl James (7 shared papers)
In The Last Decade
Thomas Kellerth
44 papers receiving 3.3k citations
Thomas Kellerth's Hit Papers
Peers
Comparison fields: 5 of 85
- Cardiology and Cardiovascular Medicine 1.3k
- Surgery 1.9k
- Internal Medicine 48
- Radiology, Nuclear Medicine and Imaging 188
- Health Information Management 50
Countries citing papers authored by Thomas Kellerth
This map shows the geographic impact of Thomas Kellerth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kellerth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kellerth more than expected).
Fields of papers citing papers by Thomas Kellerth
This network shows the impact of papers produced by Thomas Kellerth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kellerth. The network helps show where Thomas Kellerth may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kellerth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial Hit paper breakdown → | 2016 | 572 |
| 2 | Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study Hit paper breakdown → | 2021 | 384 |
| 3 | Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014 Hit paper breakdown → | 2017 | 347 |
| 4 | Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial Hit paper breakdown → | 2019 | 297 |
| 5 | Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. | 1999 | 271 |
| 6 | 2017 | 260 | |
| 7 | 2010 | 237 | |
| 8 | 2017 | 231 | |
| 9 | Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction Hit paper breakdown → | 2024 | 183 |
| 10 | 2018 | 116 | |
| 11 | 2020 | 65 | |
| 12 | FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction Hit paper breakdown → | 2024 | 62 |
| 13 | 2019 | 58 | |
| 14 | 2017 | 54 | |
| 15 | 2009 | 53 | |
| 16 | 2016 | 41 | |
| 17 | 2018 | 34 | |
| 18 | 2019 | 26 | |
| 19 | 2019 | 25 | |
| 20 | 2012 | 24 |
About Thomas Kellerth
Thomas Kellerth is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Internal Medicine, Economics and Econometrics and Health Information Management, having authored 44 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (23 papers), Coronary Interventions and Diagnostics (16 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Healthcare Policy and Management (1 paper), Cardiovascular Issues in Pregnancy (1 paper), Healthcare Systems and Public Health (1 paper), Cardiac Valve Diseases and Treatments (1 paper) and Healthcare Systems and Practices (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.3k citations), Surgery (1.9k citations), Internal Medicine (48 citations), Radiology, Nuclear Medicine and Imaging (188 citations) and Health Information Management (50 citations). Thomas Kellerth has collaborated with scholars based in Sweden, Denmark and Finland. Frequent co-authors include Tomas Jernberg, Joakim Alfredsson, David Erlinge, Troels Yndigegn, Bertil Lindahl, Annica Ravn‐Fischer, Claes Held, Stefan Karl James, Lars C. Wallentin and Karolina Elisabeth Szummer. Their work appears in journals such as European Heart Journal, The Lancet, New England Journal of Medicine, JACC: Cardiovascular Interventions and European Heart Journal - Cardiovascular Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.